6806 completed, 2050 unknown, 2022 recruiting, 1270 terminated. 4151 Not applicable, 3992 Phase 2, 2200 Phase 1, 1349 Phase 3, 285 Phase 4.
Follow Breast Neoplasms: new trials by email Literature Review of Breast Neoplasms trials Research Report on Breast Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility Trial of a Culturally Tailored Resilience Intervention for Underserved Breast Cancer Survivors BRIGHT Resilience Intervention, BRIGHT Survivorship Resource Booklet - Breast Cancer, Cancer Survivorship | Not applicable | Not yet recruiting | University College Dublin | 80 | 2029-10-01 | 2026-11-12 |
| Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer DCE-MRI - Breast Cancer, Breast Cancer With Low to Intermediate HER2 Expression | Not yet recruiting | Hao Xu | 400 | 2028-01-01 | 2026-02-05 | |
| Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer Resistant Potato Starch, Placebo control - Breast Cancer, HER-2 Positive Breast Cancer | Not applicable | Not yet recruiting | University of Vermont Medical Center | 12 | 2027-10-01 | 2026-02-12 |
| DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure blood sampling, Blood sampling - Renal Impairment, Digestive Cancers | Not yet recruiting | Centre Hospitalier Universitaire de Besancon | 742 | 2027-10-01 | 2026-11-02 | |
| Developing and Testing the Efficacy of AI-Chatbot-Based AIAI-Chatbot CalmMindRecoveryJourney delivering BMS-MC therapy - Breast Cancer | Not applicable | Not yet recruiting | National Taiwan University Hospital | 68 | 2027-08-01 | 2026-08-27 |
| EmpowerHer: Hybrid Digital Intervention for Breast Cancer Survivors EmpowerHer Hybrid Program - Breast Cancer, Cancer Survivors | Not applicable | Not yet recruiting | University of Valencia | 147 | 2027-07-01 | 2026-06-30 |
| Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer Neratinib + endocrine therapy, Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant, CDK4/6 + Endocrine therapy - Metastatic Invasive Breast Cancer, Resistant Breast Cancer | Phase 2 | Not yet recruiting | University of California, San Diego | 150 | 2027-07-01 | 2026-07-27 |
| Internal Mammary Node Irradiation After Neoadjuvant Systemic Therapy for Breast Cancer Locoregional Radiotherapy With Internal Mammary Node Irradiation, Locoregional Radiotherapy Without Internal Mammary Node Irradiation - Breast Neoplasms | Phase 3 | Not yet recruiting | Mahidol University | 1760 | 2027-07-01 | 2026-11-13 |
| Korea Post Marketing Surveillance (PMS) Study of Talzenna® Talzenna - Breast Neoplasms | Withdrawn | Pfizer | 2027-06-01 | 2026-09-14 | ||
| HEADWATERS: Gemcitabine vs Paclitaxel in Metastatic Triple-Negative Breast Cancer in Women of African Ancestry. Gemcitabine (1000 mg/m^2), Paclitaxel 80 mg/m2 weekly - Triple Negative Breast Cancer, Metastatic Triple-negative Breast Cancer | Phase 2 | Not yet recruiting | The University of The West Indies | 750 | 2027-06-01 | 2026-09-22 |
| A Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy Methods Real-Time Image Guided Radio Therapy (IGRT) - Cancer | Not applicable | Not yet recruiting | University of Sydney | 40 | 2027-06-01 | 2026-05-20 |
| Molecular Breast Imaging (MBI)-Guided Biopsy Molecular Breast Imaging, MBI-guided biopsy - Breast Cancer Detection, Breast Neoplasm | Not applicable | Not yet recruiting | Smart Breast Corp. | 250 | 2027-06-01 | 2025-08-11 |
| Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI) [18F]FMISO-PET with contrast-enhanced MRI - Triple Negative Breast Cancer | Early Phase 1 | Recruiting | University of Alabama at Birmingham | 20 | 2027-06-01 | 2026-08-17 |
| Multi-4SCAR-T Therapy Targeting Breast Cancer 4SCAR T cells - Breast Cancer | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 100 | 2027-06-01 | 2026-11-02 |
| Study of Trastuzumab Deruxtecan in Combination With Stereotactic Radiosurgery in Patients With HER2-Positive Metastatic Breast Cancer and First Diagnosis of Brain Metastases (HERBRAIN) SRS/fSRT+T-Dxd - Breast Cancer (Advanced/Metastatic) | Phase 2 | Not yet recruiting | Azienda Ospedaliero-Universitaria Careggi | 60 | 2027-05-15 | 2026-10-29 |
| Early Intervention Juzo Compression Sleeve and Glove, Compression Sleeve Sensor - Breast Cancer, Breast Cancer Treatment Related Lymphedema | Not applicable | Not yet recruiting | Massachusetts General Hospital | 40 | 2027-05-01 | 2026-07-13 |
| Cancer Awareness Among Syrian Migrants PMT-Based Cancer Screening Educational Intervention, PMT-Based Cancer Screening Education Program - Breast Cancer Screening, Cervical Cancer Screening | Not applicable | Not yet recruiting | Toros University | 30 | 2027-03-09 | 2026-10-15 |
| TROPION Breast Respond in 1L TNBC Dato-DXd - Unresectable Triple-negative Breast Cancer, Metastatic Triple-negative Breast Cancer | Not yet recruiting | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 400 | 2027-03-01 | 2026-10-09 | |
| Semaglutide for Weight Management During Hormone Therapy for Early Breast Cancer Semaglutide (Wegovy®) - Breast Cancer (Early Breast Cancer), Obesity | Phase 2 | Not yet recruiting | Aarhus University Hospital | 32 | 2027-03-01 | 2026-11-02 |
| Low-Dose Apatinib Plus Chemotherapy in ADC-Pretreated HER2-Positive and HER2-Low Advanced Breast Cancer Apatinib mesylate, Physician's choice chemotherapy - Breast Neoplasms, Advanced Breast Cancer | Phase 2 | Not yet recruiting | Yunnan Cancer Hospital | 56 | 2027-03-01 | 2026-10-30 |
Showing 20 of 14436. Sign in to see all of them.
Triple Negative Breast Neoplasms (1202) · Neoplasms (770) · Ovarian Neoplasms (698) · Colorectal Neoplasms (607) · Lung Neoplasms (605) · Neoplasm Metastasis (605) · Prostatic Neoplasms (570) · Carcinoma, Non-Small-Cell Lung (554) · Pancreatic Neoplasms (393) · Melanoma (372) · Stomach Neoplasms (370) · Colonic Neoplasms (338) · Motor Activity (298) · Breast Neoplasms, Male (286)
Skin and Connective Tissue Diseases (14436) · Skin Diseases (14422) · Neoplasms by Site (14407) · Breast Diseases (14345) · Neoplasms (13666) · Pathological Conditions, Signs and Symptoms (2043) · Urogenital Diseases (1543) · Neoplasms by Histologic Type (1518) · Urogenital Neoplasms (1453) · Genital Diseases (1385) · Pathologic Processes (1381) · Digestive System Diseases (1306) · Digestive System Neoplasms (1275) · Female Urogenital Diseases and Pregnancy Complications (1235) · Female Urogenital Diseases (1227)
Paclitaxel (654) · Trastuzumab (650) · Cyclophosphamide (620) · Docetaxel (511) · Capecitabine (451) · Letrozole (391) · Carboplatin (364) · Fulvestrant (346) · Doxorubicin (328) · Tamoxifen (283) · pembrolizumab (273) · Anastrozole (251) · Epirubicin (238) · exemestane (233) · Radiotherapy (226)
National Cancer Institute (NCI) (308) · Fudan University (260) · M.D. Anderson Cancer Center (243) · Memorial Sloan Kettering Cancer Center (240) · AstraZeneca (183) · Hoffmann-La Roche (183) · Novartis Pharmaceuticals (181) · Pfizer (161) · Mayo Clinic (152) · Dana-Farber Cancer Institute (143) · Alliance for Clinical Trials in Oncology (93) · Eli Lilly and Company (93) · City of Hope Medical Center (90) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (89) · Washington University School of Medicine (88)
United States (6239) · China (1772) · France (1222) · Spain (944) · Canada (924) · Italy (884) · United Kingdom (771) · Germany (683) · South Korea (608) · Belgium (568) · Australia (446) · Taiwan (395) · Netherlands (393) · Turkey (Türkiye) (384) · Brazil (344)
Norman Wolmark, MD (36) · Edith A. Perez, MD (18) · Biyun Wang, Professor (15)
PMID 38979716, PMID 34037241, PMID 29522361, PMID 32450725, PMID 40443562, PMID 39606939, PMID 40207789, PMID 41170811, PMID 22508812, PMID 24529560, PMID 32101663, PMID 33084020, PMID 39024777, PMID 42334791, PMID 18355913, PMID 22649152, PMID 25071111, PMID 26101239, PMID 26348120, PMID 26438146, PMID 27432417, PMID 28898379, PMID 30032196, PMID 30207593, PMID 30711522, PMID 32379297, PMID 33307491, PMID 34252375, PMID 35594464, PMID 39613746, PMID 40421669, PMID 12393820, PMID 15894097, PMID 19903919, PMID 20299316, PMID 21247627, PMID 21376385, PMID 21796368, PMID 21880792, PMID 22198468, PMID 23871490, PMID 23902874, PMID 24091623, PMID 24682463, PMID 24881463, PMID 25092775, PMID 25439688, PMID 27367583, PMID 28057664, PMID 29141853
2023 (99), 2016 (67), 2019 (57), 2014 (54), 2017 (54), 2025 (53), P30CA033572 (52), 2018 (49), 2015 (46), 2008 (37), P30CA015083 (36), 2009 (34), 2005 (32), P30CA016672 (30), P30CA043703 (30)